BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32511040)

  • 1. Epstein-Barr virus-associated lymphoproliferative disorder in a young child treated for Wilms tumor.
    Robison RA; Magaki S; Kheradpour A; Harder SL; Wang J; Yau D; Zuppan CW; Deisch JK
    Pediatr Hematol Oncol; 2020 Oct; 37(7):645-651. PubMed ID: 32511040
    [No Abstract]   [Full Text] [Related]  

  • 2. Epstein-Barr virus-associated B cell lymphoproliferative disease in a child with neonatal-onset multisystem inflammatory disease.
    Modica R; Emery H; Lam W; Hermiston M; Grenert J; Wirt M; von Scheven E
    Arthritis Rheum; 2006 Oct; 55(5):823-5. PubMed ID: 17013844
    [No Abstract]   [Full Text] [Related]  

  • 3. Concurrent classical Hodgkin lymphoma and plasmablastic lymphoma in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma treated with fludarabine: a dimorphic presentation of iatrogenic immunodeficiency-associated lymphoproliferative disorder with evidence suggestive of multiclonal transformability of B cells by Epstein-Barr virus.
    Foo WC; Huang Q; Sebastian S; Hutchinson CB; Burchette J; Wang E
    Hum Pathol; 2010 Dec; 41(12):1802-8. PubMed ID: 20869749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case report.
    Kato S; Miyata T; Takata K; Shimada S; Ito Y; Tomita A; Elsayed AA; Takahashi E; Asano N; Kinoshita T; Kimura H; Nakamura S
    Hum Pathol; 2013 Dec; 44(12):2849-52. PubMed ID: 24012167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic EBV-positive lymphoproliferative disease of childhood.
    Portsmore S; Chakravorty S; Oppong E; Ahmad R; Bain BJ
    Am J Hematol; 2015 Apr; 90(4):355. PubMed ID: 25639946
    [No Abstract]   [Full Text] [Related]  

  • 6. Epstein-Barr virus-associated post-transplant lymphoproliferative disorder of plasma cell type following allogeneic haemopoietic stem cell transplant treated with rituximab.
    Getta B; Kwan J
    Intern Med J; 2014 Aug; 44(8):821. PubMed ID: 25081050
    [No Abstract]   [Full Text] [Related]  

  • 7. Fulminant Epstein-Barr virus-driven CD8 positive T-cell lymphoproliferative disorder with chromosomal abnormality.
    Tanoshima R; Goto H; Kato H; Yokosuka T; Kajiwara R; Yokota S
    Pediatr Blood Cancer; 2011 Jul; 57(1):182. PubMed ID: 21445947
    [No Abstract]   [Full Text] [Related]  

  • 8. Epstein-Barr virus in lymphoproliferative processes: an update for the diagnostic pathologist.
    Ng SB; Khoury JD
    Adv Anat Pathol; 2009 Jan; 16(1):40-55. PubMed ID: 19098466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An adult case of severe chronic active Epstein-Barr virus infection with T-cell lymphoproliferative disorder.
    Mun SK; Lee SS; Kang SH; Lee MJ; Kim SY; Choi HG; Kang HJ
    Korean J Intern Med; 2012 Dec; 27(4):474-7. PubMed ID: 23269893
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response.
    Yang J; Tao Q; Flinn IW; Murray PG; Post LE; Ma H; Piantadosi S; Caligiuri MA; Ambinder RF
    Blood; 2000 Dec; 96(13):4055-63. PubMed ID: 11110673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactive Epstein-Barr virus-related polyclonal lymphoproliferative disorder in a patient with AIDS.
    Martin SI; Zukerberg L; Robbins GK
    Clin Infect Dis; 2005 Oct; 41(8):e76-9. PubMed ID: 16163622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-associated post-transplant lymphoproliferative disorders after allogeneic peripheral blood stem cell transplantation for Hodgkin-like adult T-cell leukemia/lymphoma.
    Yagi T; Ishikawa J; Aono N; Yamashita Y; Kusakabe S; Yoshinami T; Akazawa Y; Sakai D; Yamamoto S; Hamanaka Y; Masaie H; Sugimoto N; Yoshida H; Tomita Y; Imamura F
    Int J Hematol; 2012 Feb; 95(2):214-6. PubMed ID: 22170229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Epstein-Barr virus status and immunophenotypic studies in the evaluation of exfoliative cytology specimens from patients with post-transplant lymphoproliferative disorders.
    Gibson SE; Picarsic J; Swerdlow SH; Pantanowitz L
    Cancer Cytopathol; 2016 Jun; 124(6):425-35. PubMed ID: 26992116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-positive lymphoproliferative disorder associated with old organized chronic subdural hematoma.
    Sugita Y; Ohta M; Ohshima K; Niino D; Nakamura Y; Okada Y; Nakashima S
    Pathol Int; 2012 Jun; 62(6):412-7. PubMed ID: 22612510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful preemptive therapy with single-dose rituximab for Epstein-Barr virus infection to prevent post-transplant lymphoproliferative disease after pediatric hematopoietic stem cell transplantation.
    Kim BK; Kang HJ; Hong KT; An HY; Choi JY; Lee JS; Park SS; Shin HY
    Transpl Infect Dis; 2019 Dec; 21(6):e13182. PubMed ID: 31556214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TEN-like eruption in setting of EBV positive T-cell lymphoproliferative disease with HLH, in a child.
    Sharma N; Clark J; Pham H; Efron D; MacGregor D; O'Keefe R; Orchard D
    Australas J Dermatol; 2014 Aug; 55(3):e44-7. PubMed ID: 23573996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial spontaneous remission of posttransplantation Epstein Barr virus-related B-cell lymphoproliferative disorder of the skin in a renal transplant recipient: case report and review of the literature on cutaneous B-cell posttransplantation lymphoproliferative disease.
    Blokx WA; Andriessen MP; van Hamersvelt HW; van Krieken JH
    Am J Dermatopathol; 2002 Oct; 24(5):414-22. PubMed ID: 12357204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of a patient with Epstein-Barr virus-positive B-cell lymphoproliferative disorder resembling post-transplant lymphoproliferative disorder using single-agent rituximab.
    Maldonado NI; Cabanillas F; Jaffe ES; Raffeld M; Lozada L
    J Clin Oncol; 2011 Aug; 29(22):e658-60. PubMed ID: 21646613
    [No Abstract]   [Full Text] [Related]  

  • 19. [The cutting-edge of medicine; Epstein-Barr virus associated lymphoproliferative disorders: disease concept and treatment].
    Suzuki R
    Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):979-85. PubMed ID: 23772516
    [No Abstract]   [Full Text] [Related]  

  • 20. Endoscopic findings of small-intestinal Epstein-Barr virus-associated T-cell lymphoproliferative disorder.
    Sazuka S; Takahashi Y; Kawaguchi T; Sato T; Nakagawa T; Furuya Y; Saito M; Saito K; Katsuno T; Nakaseko C; Yokosuka O
    Endoscopy; 2012; 44 Suppl 2 UCTN():E30-1. PubMed ID: 22396263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.